Lipids and lipid management in diabetes.
Cardiovascular disease is more prevalent in type 1 and type 2 diabetes, and continues to be the leading cause of death among adults with diabetes. Although atherosclerotic vascular disease has a multi-factorial etiology, disorders of lipid metabolism play a central role. The coexistence of diabetes with other risk factors, in particular with dyslipidemia, further increases cardiovascular disease risk. A characteristic pattern, termed diabetic dyslipidemia, consists of increased levels of triglycerides, low levels of high density lipoprotein cholesterol, and postprandial lipemia, and is mostly seen in patients with type 2 diabetes or metabolic syndrome. This review summarizes the trends in the prevalence of lipid disorders in diabetes, advances in the mechanisms contributing to diabetic dyslipidemia, and current evidence regarding appropriate therapeutic recommendations.
Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Mamta
M
Jaiswal
University of Michigan Medical School, Ann Arbor, MI, USA.
Ashley
A
Schinske
Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA. Electronic address: rpbusui@umich.edu.
Rodica
R
Pop-Busui
D000328:Adult; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D048909:Diabetes Complications / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D003920:Diabetes Mellitus / Q000097:blood* / Q000453:epidemiology / Q000628:therapy*; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D008055:Lipids / Q000097:blood*; D015995:Prevalence
D008055:Lipids
cardiovascular disease; dyslipidemia; fibrates; lifestyle intervention; statins; type 1 diabetes; type 2 diabetes